InvestorsHub Logo
icon url

steelyeye

11/18/20 4:11 PM

#333787 RE: Golfguru03 #333779

Yes, exactly why Brilacidin as a 3 in 1 therapeutic, if it performs even slightly above the low bar that currently exists, will win the day.


yesterday I read up on the mutation that is going around Europe...replicates 10 times faster and more efficient as well as more infectious...but also with a new "spike" which makes it more vulnerable...called D614G..

Sounds right up Brilacidin's alley..